Laserfiche WebLink
Required DOT Drug Tests & Cutoffs <br />TYPE OF DRUG <br />INITIAL TEST <br />CONFIRMATORY TEST <br />CONFIRMATORY TEST <br />Initial Test Analyte <br />Cutoff Concentration <br />Analyte <br />Cutoff Concentration <br />Marijuana metabolites <br />50 ng/mL <br />THCA9 <br />15 ng/mL <br />Cocaine metabolites <br />150 ng/mL <br />Benzoylecgonine <br />100 ng/mL <br />Opiate metabolites: <br />Codeine/Morphine <br />2000 ng/mL <br />Codeine <br />2000 ng/mL <br />Morphine <br />2000 ng/mL <br />6-acetylmorphine (6-AM) <br />10 ng/mL <br />6-acetylmorphine (6-AM) <br />10 ng/mL <br />Phencyclidine (PCP) <br />25 ng/mL <br />Phencyclidine <br />25 ng/mL <br />Amphetamines: <br />AMP/MAMP <br />500 ng/mL <br />Amphetamine <br />250 ng/mL <br />Methamphetamine <br />250 ng/mL'a <br />MDMA <br />500 ng/mL <br />MDMA10 <br />250 ng/mL <br />MDA" <br />250 ng/ml <br />MDEA12 <br />250 ng/mL <br />Table 1 <br />9 Delta-9-tetrahydrocatmabinol-9-caTboxylic acid <br />19 Methylcucdioay ethatnpheta ni -e (MDMA). <br />11 Methylenedioxyamphetamine (MDA. <br />12 Methylenedioxyethylamph ` e (MDEA). <br />13 Specimen must also contain amphetatnine at a concentration of greater than or equal to 100 ng/mL. <br />J. RANCK ELECTRIC, INC. <br />PHMSA DRUG/ALCOHOL PLAN <br />:. NATIONAL COMPI IANCF MANAGEMENT SERVICE., INC. (NCMS) r 2010 23 <br />